References
- Leiwen F, Bingyi W, Tanwei Y, et al. “Clinical characteristics of
coronavirus disease 2019 (COVID-19) in China: A systematic review and
meta-analysis.” J Infect. 2020; 80(6): 656–665.
- Lei W, Yin S, Man L, Haoyu C, et al. “Clinical manifestations and
evidence of neurological involvement in 2019 novel coronavirus
SARS-CoV-2: a systematic review and meta-analysis.” J Neurol. 2020;
11: 1–13.
- Sarah Y and Anthony P. Fernandez. “Skin Manifestations of COVID-19.”
Cleveland Clinic Journal of Medicine, 2020; 87(6): 1-4.
- Hamming I, Timens W, Bulthuis MLC, et al. “Tissue distribution of
ACE2 protein, the functional receptor for SARS coronavirus. A first
step in understanding SARS pathogenesis.” Journal of Pathology, 2004;
203(2): 631–637.
- Li Y-C, Bai W-Z, Hashikawa T. “The neuroinvasive potential of
SARS-CoV-2 may play a role in the respiratory failure of COVID-19
patients” Med Virol, 2020; 92:552–555.
- Mao L, Jin H, Wang M, et al. “Neurologic manifestations of
hospitalized patients with coronavirus disease 2019 in Wuhan, China.”
JAMA Neurol, 2020; 77(6): 683-690.
- Mark AE, Laura B, Bhagteshwar S, et al. “Neurological associations of
COVID-19.” Lancet Neurol, 2020; 19 (9) 1-17.
- Gaurav N, Jessica HR, Gentle SS, et al. “Neurological manifestations
of COVID-19: a systematic review.” Critical Care, 2020; 24(421):
1-11.
- Christian R, Marc M, Jörg B, et al. “Hemifacial Spasm: Conservative
and Surgical Treatment Options.” Dtsch Arztebl Int. 2012; 109(41):
667–673.
- Hutchins KL, Jansen JH, Comer AD, et al. “COVID-19–Associated
Bifacial Weakness with Paresthesia: A Subtype of Guillain-Barré
Syndrome.” Am J Neuroradiology, 2020; 1-5.
- Stefan CAH and Angela W. “Diagnosis and Treatment of Vestibular
Neuritis/Neuronitis or Peripheral Vestibulopathy (PVP)? Open Questions
and Possible Answers.” Otology & Neurotology, 2017; 38(5): 1-6.
- Srikrishna VM, Ambreen R. “A Case of COVID-19-Induced Vestibular
Neuritis.” Cureus, 2020; 12(6).
- Robert WB. “Vestibular Neuritis.” N Engl J Med, 2003; 348:1027-32.
- Michael S, Vera CZ, Viktor A, et al. “Methylprednisolone,
Valacyclovir, or the Combination for Vestibular Neuritis.” N Engl J
Med, 2004; 351:354-61.
- Mark FW. “Treatment of Vestibular Neuritis.” Current Treatment
Options in Neurology, 2009; 11:41–45.
- Michael G and Brit L. “Dermatologic manifestations and complications
of COVID-19.” Am J Emerg Med, 2020; 38(9): 1715–1721.
- Muskaan S, Raffaele G, Monica S, et al. “Cutaneous manifestations of
COVID-19: Report of three cases and a review of literature.” J
Dermatol Sci, 2020. 98(2): 75-81.
- Athanassios K, Florence D, Daphné D, et al. “Coronavirus (COVID-19)
infection–induced chilblains: A case report with histopathologic
findings.” JAAD Case Rep, 2020; 6(6): 489–492.
- Sergio VG and Antonio M. “Chilblains.” CMAJ, 2012; 184(1): 67.
- Katherine KT. “A Review of Raynaud’s Disease.” Mo Med, 2016; 113(2):
123–126.
Author contribution: All the authors contributed equally to the
manuscript including review of literaure, intervewing the patient and
writing the manuscript.
Figure legend: Raynaud’s phenomenon during the acute COVID-19 infection
with bluish discoloration of the extremities
Conflict of interest: Authors do not report any conflict of interest.
Ethical approval: Not Applicable
Funding information: Not applicable.
Acknowledgements: None